Shockwave Therapy for ED

2.jpg
How does it work?

 

LiSWT is administered with a wand-like device placed near different areas of the penis. A healthcare provider moves the device along parts of your penis for about 10-15 minutes while it emits gentle pulses. No anesthesia is needed.

The pulses trigger improved blood flow and tissue remodeling in the penis. Both of these changes can lead to erections sufficient for sex.

Pricing

 

Cost per treatment: $150.00

Exosome Injection: $1200.00

Shockwave Therapy for
Erectile Dysfunction and Peyronie's Disease

 

Low-intensity Shockwave Therapy (LiSWT) is a noninvasive therapy that's been used in orthopedics for years to help heal broken bones, injured ligaments and injured endons.

LiSWT has also been used to improve wound healing. Using targeted high-energy sound waves, LiSWT can speed up tissue repair and cell growth.

Erections rely on healthy blood flow to the penile tissue. LiSWT is viewed favorably as a way of repairing and strengthening blood vessels in the penis and improving blood flow. 

Increasing blood flow to the penis is the same goal of more traditional ED treatments, such as oral medications, including Sildenafil (Viagra) and Tadalafil (Cialis).

What is the protocol?

A course of LiSWT involves typically 6-10 treatments. Each treatment lasts approximately 10-15 minutes. Treatments are typically performed either once or twice weekly (no difference in outcomes have been demonstrated in studies performing this procedure one or twice weekly).

*The cost of each treatment is $150.00

Some patients note significant improvement after as few as four treatments. It is recommended that once a patient is satisfied with their erectile function, that treatments are terminated.

After 10 treatments, therapy is discontinued for at least two months, during which time there is continued vascular proliferation and improvement in erections.

After two months, if erectile function is not satisfactory, then an injection of Exosomes (stem cell derivatives) and five more LiSWT treatments will be recommended.

*The cost of an Exosome injection is $1200.00

What does the research say?

A 2019 review and meta-analysis found that erectile function significantly improved with LiSWT. Results were best among men with vasculogenic ED.

A 2010 pilot study found that among 20 men with vasculogenic ED, all experienced improved erectile function after six months of LiSWT treatments. Follow-up with the men found no adverse effects. 

Published: 21 January 2019

Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials

Ioannis Sokolakis & Georgios Hatzichristodoulou 

International Journal of Impotence Research volume 31, pages177–194(2019)

 

Abstract:

The efficacy of low intensity extracorporeal shock wave therapy (LI-ESWT) for erectile dysfunction (ED) has received hard criticism and recently published meta-analyses were not able to provide further insights, nor specific recommendations. The aim of this systematic review and meta-analysis is to evaluate the efficacy of LI-ESWT for ED, identify the ideal treatment population and treatment protocol, and provide recommendations for future research in the field. A systematic research for relevant clinical studies published from January 2010 to September 2018 was performed, using the following databases: Medline, Embase, The Cochrane Library, Scopus, and Web of Science. Only clinical studies that investigated the efficacy of LI-ESWT for ED only, and reported primary outcomes using IIEF-EF scores/questionnaires were included. Both, randomised controlled trials (RCTs) and cohort studies were included, but the meta-analysis was performed only for sham-controlled RCTs. Ten RCTs including 873 patients were selected for the meta-analysis. Pooling data of these studies showed that LI-ESWT could significantly improve erectile function in men with ED regarding both patient-subjective outcomes (IIEF-EF: +3.97; 95% CI [2.09–5.84]; p < 0.0001, EHS ≥ 3: OR: 4.35; 95% CI [1.82–10.37]; p = 0.0009) and patient-objective outcomes (peak systolic velocity: +4.12; 95% CI [2.30–5.94]; p < 0.00001). In conclusion, the present meta-analysis provided results showing that LI-ESWT significantly improves erectile function in patients with vasculogenic ED.